• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

Article

October 4, 2022

Study Links New Type 1 Diabetes Diagnoses, Prior COVID-19 in Pediatric Patients

Author(s):

Aislinn Antrim, Managing Editor

Respiratory infections have been associated with onset of type 1 diabetes in previous research, but this risk was notably higher among those with COVID-19 in this study.

New research has found an association between new type 1 diabetes diagnoses and prior COVID-19 in pediatric patients, according to investigators whose findings were published in JAMA Network Open.

Earlier research had found that the incidence of new-onset type 1 diabetes increased during the COVID-19 pandemic and was associated with SARS-CoV-2 infection. CDC data suggest that pediatric patients with COVID-19 were more likely to be diagnosed with diabetes after infection, although types 1 and 2 were not separated. Therefore, investigators conducted a cohort study to determine whether there was an increase in new diagnoses of type 1 diabetes in pediatric patients after COVID-19.

The investigators obtained data using the TriNetX Analytics Platform, a database of deidentified electronic health records (EHR) of more than 90 million patients. The population was comprised of pediatric patients in 2 cohorts: those with SARS-CoV-2 infection between March 2020 and December 2021, and those with non-SARS-CoV-2 respiratory infection during the same period. The cohorts were then subdivided into groups aged 0 to 9 years of age and those aged 10 to 18 years.

The study population included 1,091,494 pediatric patients, 314,917 of whom had COVID-19 and 776,577 with non-COVID-19 respiratory infections. The matched cohort included 285,628 patients with COVID-19 and 285,628 with non-COVID-19 respiratory infections.

According to the study, by 6 months after COVID-19 infection, 123 patients had received a new diagnosis of type 1 diabetes, but only 72 were diagnosed with diabetes within 6 months of a non-COVID-19 respiratory infection. At 1, 3, and 6 months after infection, risk of diagnosis of type 1 diabetes was greater among those infected with SARS-CoV-2 compared to those with non-COVID-19 respiratory infection.

This increased risk was also noted in subgroups of patients aged 0 to 9 years and 10 to 18 years. Similar findings were noted among children infected with SARS-CoV-2 compared with other control cohorts at 6 months.

Based on these findings, the investigators said new type 1 diabetes diagnoses were more likely to occur among pediatric patients with prior COVID-19 than among those with other respiratory infections. Respiratory infections have been associated with onset of type 1 diabetes in previous research, but this risk was notably higher among those with COVID-19 in this study.

The findings raise concern for long-term, post-COVID-19 autoimmune complications among children, according to the study authors.

The study did have some limitations, such as potential biases due to the observational and retrospective design of the EHR analysis, including the possibility of misclassification of diabetes as type 1 versus type 2, and the possibility that additional unidentified factors accounted for the association.

The authors said that the results should be confirmed in other populations, but the findings add an important consideration for risk-benefit discussions for prevention and treatment of SARS-CoV-2 infection in pediatric population.

REFERENCE

Kendall E, Olaker V, Kaelber D. Association of SARS-CoV-2 Infection With New-Onset Type 1 Diabetes Among Pediatric Patients From 2020 to 2021. JAMA Network Open. September 23, 2022. Accessed October 3, 2022. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2796649?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092322

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit:  Artur | stock.adobe.com
Cardiovascular disease doctor or cardiologist holding red heart in clinic or hospital exam room office for csr professional medical service, cardiology health care and world heart health day concept - Image credit: Chinnapong | stock.adobe.com
Related Content
Advertisement
3D rendering of antibody drug conjugate | Image Credit: Alpha Tauri 3D - stock.adobe.com
July 14th 2025

Adjuvant Trastuzumab Emtansine Plus Trastuzumab Improved Disease-Free, Overall Survival in HER2+ Early Breast Cancer

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
July 10th 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor
Atrial fibrillation (AF) -- Image credit: ibreakstock | stock.adobe.com
July 14th 2025

FDA Approves Expanded Labeling of Farapulse PFA System for Persistent Atrial Fibrillation

Gillian McGovern, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Patient undergoing organ transplant -- Image credit: Akarawut | stock.adobe.com
July 14th 2025

Riliprubart Receives FDA Orphan Drug Designation for AMR in Solid Organ Transplantation

Gillian McGovern, Associate Editor
Pills blister pack on a white background. Top view food supplements empty packaging. Medicine shortage concept. Running out of drugs.
July 14th 2025

Bridging Gaps in Pharmacy Access

Mike Hennessy Jr, Chairman and CEO
Related Content
Advertisement
3D rendering of antibody drug conjugate | Image Credit: Alpha Tauri 3D - stock.adobe.com
July 14th 2025

Adjuvant Trastuzumab Emtansine Plus Trastuzumab Improved Disease-Free, Overall Survival in HER2+ Early Breast Cancer

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
July 10th 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor
Atrial fibrillation (AF) -- Image credit: ibreakstock | stock.adobe.com
July 14th 2025

FDA Approves Expanded Labeling of Farapulse PFA System for Persistent Atrial Fibrillation

Gillian McGovern, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
Patient undergoing organ transplant -- Image credit: Akarawut | stock.adobe.com
July 14th 2025

Riliprubart Receives FDA Orphan Drug Designation for AMR in Solid Organ Transplantation

Gillian McGovern, Associate Editor
Pills blister pack on a white background. Top view food supplements empty packaging. Medicine shortage concept. Running out of drugs.
July 14th 2025

Bridging Gaps in Pharmacy Access

Mike Hennessy Jr, Chairman and CEO
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.